Stamford, CT -- (SBWIRE) -- 10/30/2013 -- Jet Life Penny Stocks provides investors with the some of the most Awesome Penny Stock alerts on a regular basis. We will send you alerts through our Penny Stock Newsletter and offer you the tools to help you along the way with the goal of keeping you loyal to our service. Here are some trending Stocks in focus: Stevia First Corp (OTCMKTS:STVF), Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV), iShares Gold Trust(ETF) (NYSEARCA:IAU), Biozone Pharmaceuticals Inc (OTCBB:BZNE)
Stevia First Corp (OTCMKTS:STVF) experienced an upsurge of +9.33%, to a market valuation of $0.492 million per share for the previous trading session. After opening the day at $0.48 per share, volume surged to 1.72 million, moving forward from its daily average volume of 170,957 shares. The stock remained in the $0.47 to $0.52 price range during the session. Stevia First Corp., an agricultural biotechnology company, engages in the cultivation and harvest of stevia leafs; and the development of stevia products. The stevia products are used as sweeteners. The company was formerly known as Legend Mining, Inc. and changed its name to Stevia First Corp. in October 2011.
For How Long SIRI’s Gloss will Attract Investors? Find out via this report
Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV) opened its shares at the price of $1.29 for the day, its closing price was $1.25 after losing -3.10% for the day. The company traded with the total volume of 407,524 shares, while its average trading volume remained 216,788 shares. The beta of NVIV stands at 10.04. If we review the company’s graph to check its previous trends, we come to know these figures: During the last 5 trades the stock plummeted almost -20.89%. Invivo Therapeutics Holdings Corp., a development stage company, focuses on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries, peripheral nerve injuries, and other neurotrauma conditions.
Has NVIV Found The Bottom And Ready To Gain Momentum? Find Out Here
iShares Gold Trust(ETF) (NYSEARCA:IAU) percentage change reduced -0.61%, to close at $13.05 with the total traded volume of 263,089 shares.
Company’s year to date performance declining as it lost almost -19.84%. If we look at the last 6 months of trade, that is in the bearish zone with a drop of -8.68%. ishares Gold Trust (the Trust) is to own gold transferred to the Trust in exchange for shares issued by the Trust (Shares). Each Share represents a fractional undivided beneficial interest in the net assets of the Trust.
Why Should Investors Buy IAU After the Recent Fall? Just Go Here and Find Out
Biozone Pharmaceuticals Inc (OTCBB:BZNE) remained among the day losers and traded with volume of 618,608 shares in the last session, as compared to average volume of 2.60 million shares.
Its day's lowest price was $0.74 and its hit its day's highest price at $0.85. BZNE’s total market capitalization is $55.69 million along with 69.61 million shares outstanding. Biozone Pharmaceuticals, Inc., through its subsidiaries, engages in developing and manufacturing over the counter (OTC) drug products, and cosmetic and beauty products on behalf of third parties in the United States and internationally.
Will BZNE Get Buyers Even After The Recent Rally? Find Out Here
Jet Life Penny Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to. Jet Life Penny Stocks also offers free Highly-Professional Grade stock charts and video charts from one of the most experienced and well-respected chartists in the penny stock industry.
Jet Life Penny Stocks is not a registered securities advisor. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides information on highlighted stocks via press releases, newsletters and company website, but this should not be construed as a recommendation to buy or sell. Please visit the company website for a more complete list of risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)